type here...

CATEGORIES

Medication

LATEST

1234Page 2 of 4

TRENDING

EDITORS CHOICE

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Israel after October 7th is an Injured Nation Physically and Mentally

Eli Levin -
Israel starts 2024 in a stage of mourning, following October 7th Massacre in the Israeli communities along the Gaza strip border and at the...

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Surprising Link Between Probiotics, Anxiety, and Depression

Michael Hunter, MD -
MAJOR DEPRESSIVE DISORDER (MDD) IS A PREVALENT mental health condition. While clinicians commonly prescribe antidepressant medications for MDD, many do not experience full symptom relief.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories